HRT shortages cause widespread disruption for women in Britain

Women in the United Kingdom are facing significant disruptions in accessing hormone replacement therapy (HRT) due to ongoing medicine shortages. A survey by Pharmacy2U found that 61% of women taking HRT had to make repeat visits to pharmacies to collect prescriptions, while approximately 33% had to search multiple locations to find their medication.

The shortages have caused notable distress, with 40% of respondents reporting stress due to unavailability and 15% experiencing health problems related to the lack of medication. The Department of Health and Social Care has identified several products as being out of stock, specifically highlighting Estradot and FemSeven Conti patches as being among the most affected.

In response to the supply issues, the government has extended special dispensing arrangements for four strengths of Estradot hormone patches until January 8, 2027. Health experts have warned women against the risks of self-medicating with alternative solutions while waiting for supplies to stabilize.